TACSTD2 and breast carcinoma: In addition to breast cancer, Trop-2 is overexpressed in many types of epithelial cancers, including colorectal, oral, nasopharyngeal, pancreatic, gastric, gallbladder, lung, ovarian, endometrial, and cervical cancers.